Form 4: Eli Lilly CEO David Ricks Acquires Shares and Restricted Stock Units

David Ricks, CEO of Eli Lilly, reports acquisition of common stock and restricted stock units.

Summary

• On February 10, 2025, David A. Ricks, the President, Chair, and CEO of Eli Lilly & Co, acquired 55,131.56 shares of common stock at a price of $868.88 per share.
• Following the transaction, Ricks directly owns 539,613.167 shares of common stock.
• Ricks also indirectly owns 59,457 shares through a 2022 GRAT, 68,656 shares through a SLAT, 300 shares through a trust, and 7,264.97 shares through a 401(k).
• Additionally, Ricks acquired 31,932 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable on February 1, 2026, and expiring on February 1, 2026.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CEO's purchase of shares and restricted stock units suggests confidence in the company's future.

Positives

• The CEO's acquisition of shares and restricted stock units may signal confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. CEO's buying shares is generally seen as a positive sign.

Stakeholder Impact

• The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates

Keywords

David Ricks, Eli Lilly, LLY, Form 4, Beneficial Ownership, Common Stock, Restricted Stock Units, Insider Trading